VACCITECH PLC AND THE BANK OF NEW YORK MELLONDeposit Agreement • April 26th, 2021 • Vaccitech PLC • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2021 Company Industry JurisdictionDEPOSIT AGREEMENT dated as of __________, 2021 among VACCITECH PLC, a company incorporated under the laws of England and Wales (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.
DATED 2021 SERVICE AGREEMENTEntire Agreement and Former Service Agreement • April 26th, 2021 • Vaccitech PLC • Pharmaceutical preparations
Contract Type FiledApril 26th, 2021 Company Industry
DATED 2021 SERVICE AGREEMENTService Agreement • April 26th, 2021 • Vaccitech PLC • Pharmaceutical preparations
Contract Type FiledApril 26th, 2021 Company Industry
VACCITECH PLC [●] American Depositary Shares Representing [●] ORDINARY SHARES, NOMINAL VALUE £[●] PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 26th, 2021 • Vaccitech PLC • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2021 Company Industry JurisdictionThe ADSs are to be issued pursuant to a deposit agreement (the “Deposit Agreement”), dated as of [●], 2021, by and among the Company, The Bank of New York Mellon, as depositary (the “Depositary”), and holders from time to time of the American Depositary Receipts (“ADRs”) issued by the Depositary and evidencing the ADSs. The ADSs will initially represent the right to receive the Ordinary Shares deposited pursuant to the Deposit Agreement.